CapsoVision, Inc Contract Liability (Deferred Revenue)
CapsoVision, Inc (CV) had Contract Liability (Deferred Revenue) of $140.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-08-13
- 2026-06-30: Contract with Customer, Liability, Current $140.00K.
- 2026-03-31: Contract with Customer, Liability, Current $84.00K.
- 2025-12-31: Contract with Customer, Liability, Current $177.00K.
- 2025-09-30: Contract with Customer, Liability, Current $106.00K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2026-06-30 | $140.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $84.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $177.00K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $106.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $97.00K 10-Q · filed 2025-08-14 |
| 2024-12-31 | $132.00K 10-Q · filed 2026-05-14 |
| 2023-12-31 | $96.00K 10-K · filed 2026-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |